{
  "ticker": "LLY",
  "target_date": "2025-09-08",
  "actual_date": "2025-09-08",
  "collected_at": "2025-12-08T12:15:12.101620",
  "price": {
    "open": 728.64,
    "high": 741.61,
    "low": 718.17,
    "close": 737.5568237304688,
    "volume": 4534600,
    "change_1d_pct": 1.57,
    "change_7d_pct": 0.61,
    "change_30d_pct": -8.91
  },
  "technicals": {
    "rsi_14": 67.99,
    "sma_20": 706.72,
    "sma_50": 741.86,
    "macd": 1.117,
    "macd_signal": -4.847,
    "macd_histogram": 5.964,
    "bb_upper": 772.44,
    "bb_lower": 640.99,
    "price_vs_sma20_pct": 4.36,
    "price_vs_sma50_pct": -0.58,
    "volume_ratio": 0.91
  },
  "fundamentals": {
    "market_cap": 892575088640,
    "pe_ratio": 48.78344,
    "forward_pe": 43.93954,
    "price_to_book": 37.487576,
    "price_to_sales": 15.021509,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.46,
    "pct_from_52w_low": 59.62
  },
  "macro": {
    "spy": {
      "price": 647.04,
      "change_1d_pct": 0.25,
      "change_7d_pct": -0.01
    },
    "vix": {
      "level": 15.11,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.05
    },
    "dollar_index": {
      "level": 97.45
    },
    "gold": {
      "price": 3638.1
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Here's How Much You'd Have If You Invested $1000 in Eli Lilly a Decade Ago",
      "source": "Yahoo",
      "datetime": 1757366990,
      "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
      "url": "https://finnhub.io/api/news?id=d0cae16f7919c181ceeb07e729ac185ead86b5e3525f5a7aa009ac4d318687e3"
    },
    {
      "headline": "Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang",
      "source": "Yahoo",
      "datetime": 1757365500,
      "summary": "LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (\u201cImmix\u201d, \u201cCompany\u201d, \u201cWe\u201d or \u201cUs\u201d or \u201dIMMX\u201d), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that it has received a strategic investment from",
      "url": "https://finnhub.io/api/news?id=36e513605f67d3dce456b5728ac538012557c16a3f7834e1e8bd394ae5b8b526"
    },
    {
      "headline": "WHO adds GLP-1RAs to essential medicines list",
      "source": "Yahoo",
      "datetime": 1757357953,
      "summary": "Old and new-generation diabetes and obesity drugs such as Wegovy, Zepbound, Saxenda and Trulicity have made the list.",
      "url": "https://finnhub.io/api/news?id=c198d4181e763537f87f86a9cff7be9467d903af57cb578074548b23631681b1"
    },
    {
      "headline": "Eli Lilly (LLY) Announces Promising Results For Jaypirca In CLL Phase 3 Trial",
      "source": "Yahoo",
      "datetime": 1757355958,
      "summary": "Eli Lilly (LLY) recently announced positive results from its Phase 3 BRUIN CLL-313 trial, revealing significant progression-free survival improvements for its drug Jaypirca in treatment-naive CLL/SLL patients. This announcement likely played a key role in the company\u2019s 16% share price rise over the ",
      "url": "https://finnhub.io/api/news?id=2ceefd83458b2b8c556347278560c003767affd10ca8b4b05b8eded6cad06949"
    },
    {
      "headline": "Jim Cramer Recommends Eli Lilly Over Viking Therapeutics",
      "source": "Yahoo",
      "datetime": 1757350739,
      "summary": "Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer shared insights on. When a caller asked about the company during the lightning round, Cramer commented: \u201cNo, no, no. We have Eli Lilly. Why do we have to settle? Let\u2019s, don\u2019t, don\u2019t go for the raggedy rest. Let\u2019s go for the best",
      "url": "https://finnhub.io/api/news?id=8fb45392cae80e104db1b9ea1027839a7ff7b331ffcc6fec46063cc816825499"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-08",
      "description": "xslF345X05/wk-form4_1757362781.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000238/xslF345X05/wk-form4_1757362781.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412129.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"
    },
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}